Feline infectious peritonitis (FIP) is a devastating disease that was always fatal in the past until medical breakthroughs ...

Azithromycin was used early in the pandemic to treat COVID-19 in patients and has continued to be used to fight respiratory ...

The 2024-2025 mRNA COVID-19 vaccine provided moderate protection against severe outcomes, including hospitalizations and ED visits.

In patients with AF and COVID-19 who receive DOAC, 30-day mortality risk is similar for nirmatrelvir/ritonavir and RdRp ...

A major clinical trial has delivered an unexpected twist in the search for ways to fight COVID-19 and its lingering effects. Researchers at Mass General Brigham found that taking high doses of vitamin ...

In a large, randomized trial, researchers at Mass General Brigham have found that high-dose vitamin D3 did not reduce COVID-19 infection severity, but may impact long COVID outcomes.

Updated mRNA-1273 vaccine was effective against severe COVID-19 outcomes in older and high-risk adults during the 2024-2025 season.

First published in 2010, the EULAR recommendations for the management of RA, the most frequent inflammatory rheumatic disease ...

After leucovorin got public attention as a potential autism treatment, families rushed to get it. Many doctors are torn about ...

Israeli officials say overnight strikes inside Iran killed two senior figures in the country’s security leadership.